A Phase 2 Study of Once-Daily LY3502970 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 22 Nov 2024

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

06 Oct 2023 Results comparing the efficacy, safety, and tolerability of OFG in patients with obesity or overweight with weight related comorbidity, presented at the 59th Annual Meeting of the European Association for the Study of Diabetes
23 Aug 2023 The protocol has been amended as above-1) Number of treatment has been changed from 5 to 7.2) primary endpoint has been amended.
26 Jun 2023 Results presented at the 83rd Annual Scientific Sessions of the American Diabetes Association

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com